Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/30/1991 | WO1991009973A2 C. difficile specific oligonucleotides |
06/30/1991 | WO1991009960A1 Hybrid protein c |
06/30/1991 | WO1991009956A1 Artificial promoter for expressing proteins in yeast |
06/30/1991 | WO1991009877A1 Method of covalently bonding proteins to hydrophilic surfaces |
06/30/1991 | CA2072747A1 Method of covalently bonding proteins to hydrophilic surfaces |
06/30/1991 | CA2066027A1 C. difficile specific oligonucleotides |
06/30/1991 | CA2033247A1 Expression of s-locus specific glycorpotein gene in transgenic plants |
06/29/1991 | WO1991009875A1 Monoclonal antibody, hybridomas, their production and use |
06/29/1991 | CA2069872A1 Monoclonal antibody, hybridomas, their production and use |
06/28/1991 | WO1991009974A1 Diagnostic probe for detecting human stomach cancer |
06/28/1991 | CA2070995A1 Diagnostic probe for detecting human stomach cancer |
06/27/1991 | WO1991009313A1 Method for obtaining a recombinant protein and its utilization in the assay for the african swine pest virus (aspv) |
06/27/1991 | WO1991009140A1 Probe for detection of the fragile x syndrome |
06/27/1991 | WO1991009137A1 Recombinant thyrotropin receptor |
06/27/1991 | WO1991009131A1 Cloning vector for use in lactic acid bacteria |
06/27/1991 | WO1991009128A1 Dna, constructs, cells and plants derived therefrom |
06/27/1991 | WO1991009124A1 Variants of pai-2 |
06/27/1991 | WO1991009123A1 Soluble cd4 having a decreased affinity for mhc class ii antigens |
06/27/1991 | WO1991009122A1 A recombinant human factor viii derivative |
06/27/1991 | WO1991009121A2 Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides |
06/27/1991 | WO1991009116A1 Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus |
06/27/1991 | WO1991009114A1 Cell-cycle-dependent regulation of phosphorylation of human retinoblastoma gene product |
06/27/1991 | WO1991009113A1 Synthetic polypeptide with type iv collagen activity |
06/27/1991 | WO1991009070A1 Fluorinated poly(naphthyl ethers) |
06/27/1991 | WO1991009060A1 Proteinase inhibitory agents and methods for their use |
06/27/1991 | WO1991009059A1 Antibody antagonists of human interleukin-4 |
06/27/1991 | WO1991009057A1 Novel proteins with oncostatin m activity and process for their preparation |
06/27/1991 | WO1991009056A1 Octapeptide analogs of somatostatin having threonine at the sixth position |
06/27/1991 | WO1991009054A1 Type iv collagen polypeptide |
06/27/1991 | WO1991009051A1 Substituted cyclic penicillanic acid tetrapeptides |
06/27/1991 | WO1991009049A1 H. pylori specific oligonucleotides |
06/27/1991 | WO1991009045A1 Hepatocellular carcinoma oncogene |
06/27/1991 | WO1991008771A2 Method for intensive, in vitro culture of babesia divergens strains, method for preparing exoantigens and vaccines containing these antigens |
06/27/1991 | WO1991008762A1 Production of biologically active platelet-derived growth factor from high expression host cell systems |
06/27/1991 | WO1991008761A1 Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
06/27/1991 | WO1991008760A1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
06/27/1991 | WO1991008759A1 Alkyl substituted cyclic penicillanic acid pentapaptides |
06/27/1991 | WO1991008758A1 Wound treatment employing biologically active peptides |
06/27/1991 | WO1991008756A1 Novel malarial sporozoite peptide antigens |
06/27/1991 | WO1991008754A1 Medicinal application of m-csf |
06/27/1991 | WO1991008753A1 Method and composition for the treatment of mammalian hiv infection |
06/27/1991 | WO1991008749A1 Novel procedure for obtaining proteins starting from an extract of non-collagenous proteins from bony material and its use for the preparation of a novel protein inhibiting the proliferation of osteoblasts |
06/27/1991 | WO1991008675A1 Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein |
06/27/1991 | WO1991007437A3 Improved cd-30 antibodies and fragments thereof |
06/27/1991 | DE3942580A1 Verfahren zur herstellung von hirudin A process for the preparation of hirudin |
06/27/1991 | DE3942579A1 Neue proteine New proteins |
06/27/1991 | CA2070660A1 Cell-cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product |
06/27/1991 | CA2070171A1 Proteins with oncostatin m activity and process for their preparation |
06/27/1991 | CA2046594A1 Octapeptide analogs of somatostatin having threonine at the sixth position |
06/27/1991 | CA2032914A1 Use of bacterial lipoprotein amino terminus in fusion plasmids for in vivo expression of lipid modified polypeptides |
06/27/1991 | CA2006744A1 Nucleid acids and polypeptides encoded thereby |
06/26/1991 | EP0434670A1 Monoclonal antibodies |
06/26/1991 | EP0434605A2 Novel process for the production of unfused protein in E. coli |
06/26/1991 | EP0434354A1 Separation material for blood coagulation factor, preparation and use thereof |
06/26/1991 | EP0433945A2 Insecticides produced by transformation of B.t. Kurstaki with heterologeous genes |
06/26/1991 | EP0433900A1 Expression of the recombinant tumor necrosis factor binding protein I (TBP-I) |
06/26/1991 | EP0433827A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/26/1991 | EP0433744A1 Semisynthetic derivatives with immunomodulation activity, suitable for parenteral and oral administration |
06/26/1991 | EP0433509A2 Polypeptides having thyrotropin receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides |
06/26/1991 | EP0433442A1 Hybrid molecules |
06/26/1991 | EP0433437A1 Method for determining oncogenic potential of a chemical compound |
06/26/1991 | EP0433431A1 New strain with filamentous fungi mutants, process for the production of recombinant proteins using said strain, and strains and proteins produced by said process |
06/26/1991 | EP0433395A1 Stable bioactive somatotropins |
06/26/1991 | EP0433372A1 Oral immunization by transgenic plants |
06/26/1991 | EP0433371A1 Fusion protein of paramyxovirus, method of production using recombinant baculovirus expression vector, vaccine comprising such protein and use thereof |
06/26/1991 | EP0433360A1 Improvements relating to the production of prodrugs. |
06/26/1991 | EP0433345A1 Peptide synthesis method and solid support for use in the method. |
06/26/1991 | EP0433312A1 Carrier system and method for enhancement of magnetic resonance imaging |
06/26/1991 | EP0433276A1 Growth hormone related peptide |
06/26/1991 | EP0211001B1 Liver fluke antigens |
06/26/1991 | CN1052506A Recombinant japanese encephalitis molecules and methods of use therefor |
06/25/1991 | US5026839 Angiogenesis, mitotic and chemotaxic activity; stimulation of protease synthsis; equivalent to factors from human placenta |
06/25/1991 | US5026828 Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast |
06/25/1991 | US5026826 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use |
06/25/1991 | US5026686 Antiviral peptides |
06/25/1991 | US5026685 Hypotensive agents |
06/25/1991 | US5026651 Methods and compositions for the production of human transferrin |
06/25/1991 | US5026642 Stereospecificity; renin inhibitors; reducing to secondary alcohol with microorganisms containing dehydrogenase |
06/25/1991 | US5026639 Method to improve mRNA translation and use thereof for production of platelet factor-4 |
06/25/1991 | US5026636 Methods and compositions for production of mycoplasmal adhesins |
06/25/1991 | US5026635 Exposing genetically engineered cells to inhibitor, measuring decrease in protein expressed; screening viricides |
06/25/1991 | CA1285222C Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease |
06/23/1991 | WO1991009947A1 Polypeptides having serine protease inhibitor activity and dna coding therefor |
06/23/1991 | WO1991009946A1 Method of preparation of hirudin |
06/23/1991 | WO1991009945A1 Neutrophil chemoattractants |
06/23/1991 | WO1991009871A1 Hybrid molecules having translocation region and cell-binding region |
06/23/1991 | CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/23/1991 | CA2072012A1 Neutrophil chemoattractants |
06/23/1991 | CA2071969A1 Hybrid molecules having translocation region and cell-binding region |
06/23/1991 | CA2070399A1 Polypeptides and dna coding therefor |
06/23/1991 | CA2066442A1 Method of preparation of hirudin |
06/23/1991 | CA2033042A1 Methods for diagnosis of tuberculosis |
06/23/1991 | CA2032228A1 Derivatives and analogs of monoethylglycinexylidide and their production and use |
06/22/1991 | WO1991009968A1 Cd3 specific recombinant antibody |
06/22/1991 | WO1991009965A1 An improved toxin for construction of immunotoxins |
06/22/1991 | WO1991009939A1 Transformed cell lines |
06/22/1991 | CA2071998A1 Transformed cell lines |
06/22/1991 | CA2071946A1 Toxin for construction of immunotoxins |
06/22/1991 | CA2032842A1 Bovine myogenic factor gene |
06/22/1991 | CA2032607A1 Separation material for blood coagulation factor' preparation and use thereof |